Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series
Kimia Honarmand(Universidade Presbiteriana Mackenzie), John Basmaji, Karishma Desai(Western University), Ian Ball(Western University), Claudio M. Martin(Western University), Marat Slessarev(Western University), Danielle Leblanc(Western University), Sameer Elsayed(Western University), Alejandro Lazo‐Langner(Western University), Daniel Gillett(Cambridge University Hospitals NHS Foundation Trust), Kyle Fiorini(Western University), Mike J. Nicholson(Western University), Tina Mele(Western University), Robert Arntfield(London Health Sciences Centre), Debarati Chakraborty(Western University), Karen J. Bosma(Western University)
Cited by 4
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597